Method of treatment of EGFR inhibitor toxicity

Details for Australian Patent Application No. 2010236016 (hide)

Owner Peter MacCallum Cancer Institute

Inventors Zalcberg, John R.

Agent Davies Collison Cave

Pub. Number AU-A-2010236016

Priority 61/300,123 01.02.10 US

Filing date 26 October 2010

Wipo publication date 18 August 2011

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 November 2010 Complete Application Filed

  Priority application(s): 61/300,123 01.02.10 US

18 August 2011 Application Open to Public Inspection

  Published as AU-A-2010236016

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236017-A system and method of managing an insurance policy

2010236015-Gain control and frequency stability in digitally-channelised RF bi-directional amplifiers